본문 바로가기
KERD
논문KCI 등재

澤瀉가 유리지방산으로 유발된 HepG2 cell의 lipoapoptosis에 미치는 영향

The Effect of Alisma orientale Extract on Free Fatty Acid-induced Lipoapoptosis in HepG2 Cells

0

조회

0

다운로드

5

인용

0

참고문헌

키워드

주제분류한의학

초록

Objectives : This study was designed to investigate the effect on lipoapoptosis of Alisma orientale extract against free fatty acid-induced cellular injury. Methods : HepG2 cells were used in an vitro model. HepG2 cells were treated with free fatty acids to generate a cellular model of nonalcoholic fatty liver disease (NAFLD). Using this cellular model, the anti-apoptotic effect and reducing steatosis of Alisma orientale extract against free fatty acid-induced cellular injury was evaluated by measuring steatosis and apoptosis. Results : Alisma orientale extract significantly attenuated free fatty acid-induced intracellular steatosis. Alisma orientale extract inhibited free fatty acid-mediated activation of pJNK, PUMA, BAX, caspase-3, and –9, and apoptotic kinases that are correlated with NAFLD. Alisma orientale extract also promoted Bcl-2, a anti-apoptotic protein. Conclusions : From the above, the Alisma orientale extract decreased the hepatocyte steatosis and showed the hepatocelluar protective effect by the regulation of apoptosis-related protein. It proposes the possibility of Alisma orientale extract to the treatment of nonalcoholic fatty liver disease in clinics.

Abstract

Objectives : This study was designed to investigate the effect on lipoapoptosis of Alisma orientale extract against free fatty acid-induced cellular injury. Methods : HepG2 cells were used in an vitro model. HepG2 cells were treated with free fatty acids to generate a cellular model of nonalcoholic fatty liver disease (NAFLD). Using this cellular model, the anti-apoptotic effect and reducing steatosis of Alisma orientale extract against free fatty acid-induced cellular injury was evaluated by measuring steatosis and apoptosis. Results : Alisma orientale extract significantly attenuated free fatty acid-induced intracellular steatosis. Alisma orientale extract inhibited free fatty acid-mediated activation of pJNK, PUMA, BAX, caspase-3, and –9, and apoptotic kinases that are correlated with NAFLD. Alisma orientale extract also promoted Bcl-2, a anti-apoptotic protein. Conclusions : From the above, the Alisma orientale extract decreased the hepatocyte steatosis and showed the hepatocelluar protective effect by the regulation of apoptosis-related protein. It proposes the possibility of Alisma orientale extract to the treatment of nonalcoholic fatty liver disease in clinics.

참고문헌 (28)

  1. Sanyal AJ, "Endpoints and clinical trial design for nonalcoholic steatohepatitis", Hepatology, 54, pp.344~353 (2011)
  2. Serfaty L, "Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis", Diabetes Metab, 34, pp.634~637 (2008)
  3. Park SH, "Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults", JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 21, pp.138~143 (2006), BLACKWELL PUBLISHING
  4. Musso G, "Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity", Ann Med, 43(8), pp.617~649 (2010)
  5. Bellentani S, "Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD)", Ann Hepatol, 8(suppl.1), pp.S4~S8 (2009)
  6. Musso G, "Diagnostic accuracy of adipose insulin resistance index and visceral adiposity index for liver histology and cardiovascular risk in NAFLD", Hepatology, 56(2), pp.788~789 (2012)
  7. Gregor M, "Thematic review series: Adipocyte biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease", J Lipid Res, 48, pp.1905~1914 (2007)
  8. 대한간학회, "비알코올 지방간질환 진료 가이드라인", pp.17~27 (2013), 대한간학회
  9. Xiu RJ, "Microcirculation and traditional Chinese medicine", JAMA, 260, pp.1755~1757 (1988)
  10. Han CW, "Aqueous extract of Alisma oriental Attenuates palmitate-induced cellular injury by inhibiting production of reactive oxygen species in HepG2 cells", 박사, pp.2010
  11. Rhew KY, "Antioxidative Effects of Dichloromethane Extract of Alisma orientale on Non-alcoholic Fatty Liver Disease Induced by Methionine and Choline-deficient (MCD) Diet", 박사, pp.2012
  12. Nehra V, "Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis", Dig Dis Sci, 46(11), pp.2347~2352 (2001)
  13. McGarry JD, "Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes", Diabetes, 51, pp.7~18 (2002)
  14. Musso G, "Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis", Hepatology, 37, pp.909~916 (2003)
  15. De Almeida IT, "Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis", Clin Nutr, 21, pp.219~223 (2002)
  16. Baylin A, "Adipose tissue biomarkers of fatty acid intake", Am J Clin Nutr, 76, pp.750~757 (2002)
  17. Ricchi M, "Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes", J Gastroenterol Hepatol, 24(5), pp.830~840 (2009)
  18. Belfort R, "A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis", N Engl J Med, 355, pp.2297~2307 (2006)
  19. Lei K, "JNK phosphorylation of Bim-related members of Bcl2 family induces BAX-dependent apoptosis", Natl Acad Sci USA, 100, pp.2432~2437 (2003)
  20. Yamamoto K, "BCL-2 is phosphorylated and inactivated by an ASK1", Jun N-terminal protein kinase pathway normally activated at G(2), Mol Cell Biol, pp.1999, 19[DOI]
  21. Jeffers JR, "Puma is an essential mediator of p53-dependent and -independent apoptotic pathways", Cancer Cell, 4, pp.321~328 (2003)
  22. Luo X, "Transcriptional upregulation of PUMA modulates endoplasmic reticulum calcium pool depletion-induced apoptosis via Bax activation", Cell Death Differ, 12, pp.1310~1318 (2005)
  23. Taylor RC, "Apoptosis: controlled demolition at the cellular level", Nat Rev Mol Cell Biol, 9(3), pp.231~241 (2008)
  24. Findly HW, "Expression and regulation of Bcl-2, Bcl-xL, Bax correlate with p53 status and sensitivity to apoptosis in childhood acute lymphoblastic leukemia", Blood, 89(8), pp.2986~2993 (1997)
  25. Ikeda H, "Kuroiwa M. Bcl-2 Oncoprotein Expression and apoptosis in neuroblastoma", Journal of Pediatric surgery, 30(6), pp.805~808 (1996)
  26. Itoh N, "Effect of bcl-2 on Fas antigen-mediated cell death", The journal of immunology, 151(2), pp.621~627 (1993)
  27. Ginsberg D, "Wild-type p53 can down-modulate the activity of various promoters", Proc Natl Acad Sci USA, 88(22), pp.9979~9983 (1991)
  28. Schlesinger PH, "Comparison of the ion channol characteristics of proapoptotic BAX and antiapoptotic BCL-2", proc natl Acad Sci USA, 94(21), pp.11357~11362 (1997)

관련 논문AI추천

이 간행물의 다른 논문 (8건)